Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Versus Graft Host Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT00128973
What this trial is testing

Evaluation of Patients With Immune Function Abnormalities

Who this might be right for
Chronic Granulomatous Disease (CGD)X-Linked Severe Combined Immune Deficiency (XSCID)Leukocyte Adhesion Deficiency 1 (LAD)+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 3,500
Testing effectiveness (Phase 2)Active Not RecruitingNCT02669251
What this trial is testing

Alvelestat (MPH966), an Oral Neutrophil Elastase Inhibitor, in Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Chronic Graft vs Host DiseaseChronic Graft-Versus-Host DiseaseBronchiolitis Obliterans Syndrome
National Cancer Institute (NCI) 14
Testing effectiveness (Phase 2)Study completedNCT03790332
What this trial is testing

Phase 1/2 Dose Finding and Safety Study of Ibrutinib in Pediatric Subjects With Chronic Graft Versus Host Disease (cGVHD)

Who this might be right for
Chronic Graft Versus Host Disease
Pharmacyclics LLC. 59
Large-scale testing (Phase 3)Study completedNCT01231412
What this trial is testing

Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAggressive Non-Hodgkin Lymphoma+16 more
Fred Hutchinson Cancer Center 174
Testing effectiveness (Phase 2)Study completedNCT01161628
What this trial is testing

Rituximab for the Primary Treatment of Denovo Extensive Chronic Graft Versus Host Disease (GVHD)

Who this might be right for
Chronic Graft-versus-host Disease
Northside Hospital, Inc. 25
Post-approval studies (Phase 4)Study completedNCT00003398
What this trial is testing

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
AnemiaGraft Versus Host DiseaseLeukemia+3 more
University of Maryland, Baltimore 45
Very early researchWithdrawnNCT05515692
What this trial is testing

Electron Beam Radiotherapy for the Treatment of Refractory Sclerodermatous Chronic Graft Versus Host Disease

Who this might be right for
Hematopoietic and Lymphoid System NeoplasmMalignant Solid NeoplasmRefractory Sclerodermatous Graft Versus Host Disease
City of Hope Medical Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT03954236
What this trial is testing

Study of the Safety and Efficacy of Ruxolitinib Cream for Non-Sclerotic Chronic Cutaneous Graft-Versus-Host Disease

Who this might be right for
Non-sclerotic Cutaneous Chronic Graft-versus-host Disease
Memorial Sloan Kettering Cancer Center 24
Testing effectiveness (Phase 2)Ended earlyNCT00005641
What this trial is testing

Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+2 more
H. Lee Moffitt Cancer Center and Research Institute
Testing effectiveness (Phase 2)Ended earlyNCT00675441
What this trial is testing

Lenalidomide (Revlimid®) as Second Line Therapy in Patients With Chronic Graft-Vs-Host Disease (GVHD)

Who this might be right for
Graft-versus-Host Disease
M.D. Anderson Cancer Center 5
Early research (Phase 1)Ended earlyNCT02231710
What this trial is testing

Safety Study of Gene Modified Donor T Cell Infusion After Stem Cell Transplant for Non-Malignant Diseases

Who this might be right for
Primary Immune Deficiency DisordersHemophagocytic LymphohistiocytosisInherited Bone Marrow Failure Syndrome+2 more
Bellicum Pharmaceuticals 1
Early research (Phase 1)Active Not RecruitingNCT01937468
What this trial is testing

Trial of Regulatory T-cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease

Who this might be right for
Chronic Graft Versus Host DiseaseChronic GVHDComplications of Organ Transplant Stem Cells
Dana-Farber Cancer Institute 25
Early research (Phase 1)Study completedNCT03207958
What this trial is testing

Belimumab for Prevention of Chronic Graft-versus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Graft Vs Host DiseaseGraft-versus-host-disease
Washington University School of Medicine 10
Large-scale testing (Phase 3)Study completedNCT01699412
What this trial is testing

Clinical Trial With Clobetasol and Dexamethasone for Topical Treatment of Oral Lesions of Chronic Graft-versus-host Disease

Who this might be right for
Graft vs Host DiseaseOral Manifestations
Grupo de Estudos Multicentricos em Onco-Hematologia 28
Early research (Phase 1)Looking for participantsNCT06462365
What this trial is testing

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

Who this might be right for
Hematologic MalignancyGvHDGVHD,Acute+8 more
Tr1X, Inc. 36
Post-approval studies (Phase 4)Active Not RecruitingNCT02386800
What this trial is testing

CINC424A2X01B Rollover Protocol

Who this might be right for
Primary MyelofibrosisPolycythemia VeraGraft Versus Host Disease+2 more
Novartis Pharmaceuticals 279
Testing effectiveness (Phase 2)Study completedNCT02513498
What this trial is testing

Ixazomib Citrate in Treating Patients With Chronic Graft-versus-Host Disease

Who this might be right for
Chronic Graft Versus Host Disease
Fred Hutchinson Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT02065154
What this trial is testing

Post Transplant Cyclophosphamide (Cytoxan) for GvHD Prophylaxis

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndrome+3 more
University of Alabama at Birmingham 39
Testing effectiveness (Phase 2)Study completedNCT02759731
What this trial is testing

Study of Baricitinib, a JAK1/2 Inhibitor, in Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Chronic Graft vs Host DiseaseChronic Graft-Versus-Host Disease
National Cancer Institute (NCI) 24
Large-scale testing (Phase 3)Study completedNCT00755040
What this trial is testing

Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Vanderbilt-Ingram Cancer Center 164
Next Page